Aggregated News

http://www.bioedge.org/index.php/bioethics/bioethics_article/11148
Untitled Document Dr Carmel Shalev, of Israel’s Haifa University, is organising a session on helpful and harmful practices in the ethics and regulation of inter-country medically assisted reproduction in Jerusalem in January. It will be part of the 10th World Conference on Bioethics, Medical Ethics and Health Law. Untitled Document

BioEdge: “inter-country medically assisted reproduction” – do you basically mean a market for surrogate mothers and babies?

Shalev: Yes, that’s a major concern, but not the only one. For example, there is also a market in inter-country egg donations. The problem is that there have been too many cases of harm to children and to the third-party women who agree to take part in reproductive collaborations for the benefit of others, as genetic mothers (egg providers) and birth mothers (surrogate mothers).

What are the “products” in the market?

The products in surrogacy are children. In other practices the products are human gametes (eggs and sperm) and embryos (fertilised eggs). Unfortunately, women are being used as a means of production, and objectified in the process.

How much has...

Other Countries
Assisted Reproduction